Quick Order Cart

Cat. No. ARG34054

IFIH1 Knockout A549 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Lung

  • Disease:

    Lung adenocarcinoma

The IFIH1 Knockout A-549 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal population of A-549 cells with targeted disruption of the IFIH1 gene, which encodes MDA5, a cytosolic sensor of viral double-stranded RNA. IFIH1 propagates signals via MAVS to activate IRF3/IRF7 and NF-??B, leading to type I interferon and pro-inflammatory cytokine expression. These cells provide a relevant model to investigate innate antiviral pathways and interferon signaling in a human lung epithelial background. They are suitable for viral infection studies with SARS-CoV-2 or influenza, poly I:C stimulation experiments, and functional readouts such as IFN-?? ELISA, phospho-IRF3 immunoblotting, and global transcriptomic analysis.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    A549

    Sex of Donor

    Male

    Age

    58 years

    Derived From Site

    Lung

    Gene Name

    IFIH1

    Gene Identifier

    NCBI Gene ID 64135

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    MEM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The IFIH1 Knockout A-549 Polyclonal Cells are a CRISPR/Cas9-edited population of A-549 cells with targeted disruption of the IFIH1 gene, generating a heterogeneous polyclonal knockout model for the cytoplasmic dsRNA sensor MDA5. This product offers a versatile platform for loss-of-function studies in innate antiviral immunity, eliminating the need for single-cell cloning while preserving genetic diversity.

The parental A-549 cell line is an adherent epithelial line derived from a lung adenocarcinoma of a 58-year-old male. It serves as a well-characterized in vitro model of human alveolar type II epithelium and is widely employed in cancer biology, drug discovery, and viral infection research, particularly for respiratory pathogens that target the pulmonary epithelium.

IFIH1 (MDA5) recognizes long double-stranded RNA from viral genomes or synthetic analogs like poly I:C. Upon ligand binding, IFIH1 interacts with the adaptor protein MAVS, triggering activation of the kinases TBK1 and IKK??, which phosphorylate IRF3 and IRF7, leading to type I interferon (IFN-??/??) production. Parallel NF-??B activation induces pro-inflammatory cytokines. IFIH1 function is modulated by interactions with RIG-I, LGP2, and TRIM25, and is targeted by viral antagonists such as paramyxovirus V proteins.

In the A-549 epithelial context, IFIH1 disruption abrogates the major cytoplasmic RNA-sensing pathway, providing a clean genetic background to analyze host responses to respiratory viruses including SARS-CoV-2, influenza A virus, and picornaviruses. The model is also instrumental in studying IFIH1 gain-of-function mutations linked to Aicardi-Gouti??res syndrome and Singleton-Merten syndrome, and in evaluating compensatory signaling by RIG-I.

These polyclonal knockout cells are suitable for a range of experimental applications, including viral infection assays (plaque or immunofluorescence readouts), poly I:C stimulation to assess alternative pathways, and quantitative measurement of IFN-?? production by ELISA. Knockout validation can be performed by RT-qPCR for IFIH1 mRNA and western blotting for MDA5 and key signaling mediators such as phosphorylated TBK1, IRF3, and STAT1. Global transcriptional responses can be examined by RNA-seq, and interferon-stimulated gene expression (e.g., CXCL10) can serve as a functional readout. For further technical information or custom applications, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)